Vicarius Pharma bridges the gap between traditional go-it-alone and out-licensing entry strategies for Europe. Vicarius is the partner of choice for non-European companies seeking to commercialize their first product across Europe without having to out-license to a larger pharmaceutical partner or build their own commercial organization overseas. We are launch experts with unmatched experience and a deep understanding of the European markets. We work as our partners’ European go-to-market organization. We commercialize their assets in Europe, providing strategic advice on regulatory, pricing and commercial strategy, holding the marketing authorization and taking legal and operational responsibility for the asset in Europe. Vicarius’ business model is particularly attractive for companies with specialty, rare disease and hospital products. Vicarius Pharma is based in Switzerland.
| Website | http://www.vicarius-pharma.com |
| Revenue | $7 million |
| Employees | 1 (1 on RocketReach) |
| Founded | 2016 |
| Phone | +41 41 852 22 44 |
| Technologies | |
| Industry | Pharmaceutical Manufacturing, Manufacturing General, Asset Management, Manufacturing, Financial Services, Commercial, Marketing, Sales and Marketing, Pharmaceutical, Health Care |
| Competitors | Roche, Pfizer, Boehringer Ingelheim, Amgen, AstraZeneca, Novartis, Gilead Sciences, Johnson & Johnson, Sanofi, Merck AH +39 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies |
Looking for a particular Vicarius Pharma employee's phone or email?
The Vicarius Pharma annual revenue was $7 million in 2026.
Barbara Briggs is the Senior Director Regulatory Affairs of Vicarius Pharma.
1 people are employed at Vicarius Pharma.
The NAICS codes for Vicarius Pharma are [3254, 325, 32541, 32].
The SIC codes for Vicarius Pharma are [28, 283].